The antiangiogenic factor sFLT1, which antagonizes circulating bioavailable VEGF and PlGF, is significantly elevated in women with preeclampsia (44) and is thought to be specifically upregulated as a result of placental ischemia (16). This evidence concerns the gene VEGFA and preeclampsia.